Home›Stock Screener›Beta Drugs›P/B Ratio

Beta Drugs P/B Ratio

Current P/B Ratio
10.54
High Valuation
Very High - Significant premium, high growth expectations or speculative

Beta Drugs (BETA) P/B ratio is 10.54 (High), book value per share ₹245.00 vs Healthcare average P/B of -0.31 — Very High - Significant premium, high growth expectations or speculative. Review BETA price earnings ratio to evaluate earnings-based valuation against sector peers.

Current Valuation Metrics

P/B Ratio 10.54
Current Price ₹2315.60
Book Value/Share ₹245.00
Exchange NSE

Book Value Breakdown (2026)

Balance Sheet Components
Total Equity ₹245 Cr
Share Capital ₹10 Cr
Reserves & Surplus ₹235 Cr
Outstanding Shares 10,000,000
Book Value per Share ₹245.00

Valuation Signal

Signal Overvalued
Historical Avg 8.65
Historical Range 7.86 - 9.45
Percentile 100.0%

Sector Context

Sector Average -0.31
Sector Median 0.57
Sector Rank #11 of 50
Sector Percentile 22.0%

BETA P/B Ratio — Valuation Insights & Book Value Analysis

Beta Drugs price-to-book ratio interpretation, valuation status and historical context — current P/B 10.54 (High). For live price, earnings yield and the full fundamental profile, see BETA screener.

  • Stock appears overvalued with PB of 10.54, trading at significant premium to book value
  • Trading at high premium to book value - indicates strong growth expectations or asset-light business model
  • Current PB is 21.8% above historical average
  • Trading at premium to sector average PB of -0.31

Beta Drugs P/B Ratio Historical Trend

BETA annual price-to-book ratio — 2 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View BETA price range for the annual high/low range and current price position.

BETA Historical P/B Ratio — Book Value Per Share & Year-End Price

Beta Drugs annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2026 9.45 ₹245.0 ₹2315.60 ₹245 High
2025 7.86 ₹197.0 ₹1549.10 ₹197 High

BETA vs Healthcare Peers — P/B Ratio Comparison

Beta Drugs P/B 10.54 vs Healthcare average -0.31, median 0.57 — range -14.47–1.1.

Sector Average
-0.31
Sector Median
0.57
Lowest P/B
-14.47
Highest P/B
1.1
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Rekvina Laboratories VINRKLB -14.47 ₹18 Low
Span Divergent SDL -6.32 ₹19 Low
Parmax Pharma PARMAX -5.61 ₹39 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -2.22 ₹72 Low
Krebs Biochemicals & Ind… KREBSBIO -0.71 ₹115 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.5 ₹44 Low